L
Lawrence Blonde
Researcher at Ochsner Medical Center
Publications - 168
Citations - 12681
Lawrence Blonde is an academic researcher from Ochsner Medical Center. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 47, co-authored 163 publications receiving 11360 citations.
Papers
More filters
Journal ArticleDOI
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B. Buse,Julio Rosenstock,Giorgio Sesti,Wolfgang E. Schmidt,Eduard Montanya,Jason Brett,Marcin Zychma,Lawrence Blonde +7 more
TL;DR: Liraglutide once a day provided significantly greater improvements in glycaemic control than did exenatide twice a day, and was generally better tolerated, suggesting that liragLutide might be a treatment option for type 2 diabetes, especially when weight loss and risk of hypoglycaemia are major considerations.
Journal ArticleDOI
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
Bernard Zinman,John E. Gerich,John B. Buse,Andrew Lewin,Sherwyn Schwartz,Philip Raskin,Paula M Hale,Milan Zdravkovic,Lawrence Blonde +8 more
TL;DR: Liraglutide combined with metformin and a thiazolidinedione is a well-tolerated combination therapy for type 2 diabetes, providing significant improvements in glycemic control and C-peptide and homeostasis model assessment of β-cell function.
Journal ArticleDOI
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
Helena W. Rodbard,Lawrence Blonde,Susan S. Braithwaite,Elise M. Brett,Rhoda H. Cobin,Yehuda Handelsman,Richard Hellman,Paul S. Jellinger,Lois Jovanovic,Philip T. Levy,Jeffrey I. Mechanick,Farhad Zangeneh +11 more
TL;DR: These guidelines are intended to provide a single source of information for clinicians to assess the appropriateness of using EMT in the treatment of central giant cell granuloma.
Journal ArticleDOI
Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm--2016 executive summary.
Alan J. Garber,Martin J. Abrahamson,Joshua I. Barzilay,Lawrence Blonde,Zachary T. Bloomgarden,Michael A. Bush,Samuel Dagogo-Jack,Ralph A. DeFronzo,Daniel Einhorn,Vivian Fonseca,Jeffrey R. Garber,W. Timothy Garvey,George Grunberger,Yehuda Handelsman,Robert R. Henry,Irl B. Hirsch,Paul S. Jellinger,Janet B. McGill,Jeffrey I. Mechanick,Paul D. Rosenblit,Guillermo E. Umpierrez +20 more
TL;DR: This chapter discusses the development and use of eicosapentaenoic acid as a treatment for diabetic ketoacidosis and its applications in conventional and regenerative medicine.
Journal ArticleDOI
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Yehuda Handelsman,Zachary T. Bloomgarden,George Grunberger,Guillermo E. Umpierrez,Robert S. Zimmerman,Timothy S. Bailey,Lawrence Blonde,George A. Bray,A. Jay Cohen,Samuel Dagogo-Jack,Jaime A. Davidson,Daniel Einhorn,Om P. Ganda,Alan J. Garber,W. Timothy Garvey,Robert R. Henry,Irl B. Hirsch,Edward S. Horton,Daniel L. Hurley,Paul S. Jellinger,Lois Jovanovič,Harold E. Lebovitz,Derek LeRoith,Philip T. Levy,Janet B. McGill,Jeffrey I. Mechanick,Jorge H. Mestman,Etie S. Moghissi,Eric A. Orzeck,Rachel Pessah-Pollack,Paul D. Rosenblit,Aaron I. Vinik,Kathleen Wyne,Farhad Zangeneh +33 more
TL;DR: These guidelines are a working document that reflects the state of the field at the time of publication and any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.